NRx Pharmaceuticals, Inc. today announced its Chief Executive Officer, Stephen Willard, and other executive leaders will be presenting an update to the company’s business at the H.C. Wainwright & Co. 24th Annual Global Investment Conference.
Sep. 8, 2022NRx Pharmaceuticals Leaders to Present at the H.C. Wainwright & Co. 24th Annual Global Investment Conference
Aug. 2, 2022CEO Update on Recent Findings Related to Serotonin and its Role in Depression
In light of recent findings related to serotonin and its role in depression, investors have asked us to provide more specific information on the primary target addressed by D-cycloserine, a component of NRX-101.
Jul. 13, 2022NRx Pharmaceuticals Announces the Appointment of Stephen Willard, Chief Executive Officer and Director
NRx Pharmaceuticals, Inc. today announced the appointment of Stephen Willard, as its Chief Executive Officer and a member of the Company’s Board of Directors.